Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target.
Neuropsychological dysfunction associated with cancer and cancer treatment is a growing concern. Methodological limitations permeate the corpus of research in this area and have limited our understanding of the multifactorial nature of this process. The following review provides a summary of the current state of knowledge and highlights future directions.
Wefel
J S
JS
Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 431, Houston, TX 77030-4009, USA.
Kayl
A E
AE
Meyers
C A
CA
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D016543:Central Nervous System Neoplasms / Q000628:therapy*; D003071:Cognition / Q000187:drug effects*; D006728:Hormones / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects; D001523:Mental Disorders / Q000139:chemically induced*; D009483:Neuropsychological Tests; D011878:Radiotherapy / Q000009:adverse effects*
D000970:Antineoplastic Agents; D006728:Hormones